Drug might help breast cancer patients avoid heart damage

Orlando: A new study suggests there may be a way to help prevent the heart damage that many breast cancer patients suffer as a result of their treatment.

Radiation and some cancer medicines beat the disease but can harm women's hearts. Patients now are sent to cardiologists for treatment after the damage has already occurred.

In a study in Norway, researchers tried to prevent the damage, by giving a drug already widely used to treat heart failure at the time women were having cancer treatment. The drug seemed to prevent heart decline but the effect was modest. A larger study is underway now to test this further.

Subscribe ETHealthworld Newsletter

Lyrica, known generically as pregabalin, was originally developed for epilepsy but further research showed it could also help patients suffering from neuropathic pain, which soon became its main market.

With this acquisition, Nephroplus will further strengthen its servicing capacity as the dominant dialysis centre network and will have a presence in 18 states of India with 176 centers across 97 cities.